ADO 0.00% 2.0¢ anteotech ltd

flowcytomix, page-6

  1. 2,070 Posts.
    Check those numbers twin, youve halved it twice. Should be $3.2m = cashflow positive (estimated 10% royalty on $32m inferred revenue achieved by the FlowCytomix product, = approx 50% of the total ebio revenue stream).

    All IMHO only

    Good luck to holders.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $49.36M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $21.31K 1.053M

Buyers (Bids)

No. Vol. Price($)
23 5730857 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 724070 5
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.